“…Most of these studies reported a high specificity and a sensitivity above 50%, reaching 91% (Abuaf et al, 1999;Kvedariene et al, 2006;Laxenaire et al, 1999;Monneret et al, 2002;Moss, 1995;Stellato et al, 1991). This sensitivity is lower (36%) when the marker CD203c is used (Sudheer et al, 2005). However, results are discordant; Kvedarine et al (Kvedariene et al, 2006) observed in 47 patients a sensitivity of 36% and a specificity of 93% performing BAT (CD63 in whole blood).…”